J3111 Injection. romosozumab-aqqg 1 milligrams
J-Codes
Also known as: romosozumab, Evenity, sclerostin inhibitor
Romosozumab-aqqg (Evenity) 1 milligram injection is a humanized monoclonal antibody that inhibits sclerostin for osteoporosis treatment with rapid bone formation.
Clinical Context
Indicated for postmenopausal osteoporosis in women at high fracture risk. Inhibits sclerostin to promote bone formation and reduce bone resorption. Administered monthly via subcutaneous injection for 12 months.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.